PNC Financial Services Group
TRVI icon

PNC Financial Services Group’s Trevi Therapeutics TRVI Stock Holding History

PNC Financial Services Group’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6K Buy
783
+162
+26% +$2.36K ﹤0.01% 3923
2026
Q1 		$7.41K Sell
621
-378
-38% -$4.23K ﹤0.01% 4087
2025
Q4 		$12.5K Buy
999
+414
+71% +$4.79K ﹤0.01% 3862
2025
Q3 		$5.35K Sell
585
-6
-1% -$45 ﹤0.01% 4174
2025
Q2 		$3.23K Buy
591
+6
+1% +$37 ﹤0.01% 4273
2025
Q1 		$3.68K Buy
+585
New +$2.79K ﹤0.01% 4164

Other funds holding TRVI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PNC Financial Services Group's TRVI Position: Q2 2026 in Review

PNC Financial Services Group increased its Trevi Therapeutics (TRVI) stake by 26% in Q2 2026, buying an estimated $2.36K and bringing the position to 783 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3923.

PNC Financial Services Group first reported a position in TRVI in Q1 2025 and has held it in 6 quarters since. 69 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • PNC Financial Services Group held 783 shares of Trevi Therapeutics worth $14.6K as of Q2 2026.
  • PNC Financial Services Group bought 162 Trevi Therapeutics shares in Q2 2026, an estimated $2.36K.
  • Trevi Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3923 holding.
  • PNC Financial Services Group first reported a position in Trevi Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 69 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.